Patients usually attempt to manage their discogenic pain through a variety of nonsurgical and interventional treatments. These measures often include pain medications, exercise programs, physical therapy and spinal injections. While these conservative treatments attempt to manage patients’ pain, they do not directly address the suspected anatomical source of their pain. When these conservative measures fail to provide adequate pain relief, patients are faced with the prospect of a surgical intervention to remove the painful disc. Spinal fusion is the most common surgical treatment for discogenic pain. Alternative surgical procedures, including total disc replacement, nucleus replacement and dynamic stabilization, have recently become available or are currently being studied in clinical trials.
As scientists and physicians have learned more about the origins of discogenic pain, they have begun to research new biologic-based therapies with the goal of helping the body to repair or regenerate the damaged intervertebral disc. Spinal Restoration has developed an investigational biologic product and delivery system, called the Biostat® System, for use in the treatment of discogenic pain. The Biostat System is the first investigational biologic therapy for discogenic pain to enter into a Phase III human clinical study.
To learn more about the Biostat System, please visit our Products page. For more details about our Phase III clinical trial, please visit our Clinical Trials page.